Cargando…

GRK2 Enforces Androgen Receptor-Dependence in the Prostate and Prostate Tumors

Metastatic tumors that have become resistant to androgen deprivation therapy represent the major challenge in treating prostate cancer. Although these recurrent tumors typically remain dependent on the androgen receptor (AR), non-AR-driven tumors that also emerge are particularly deadly and becoming...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adler, Adam J., Mittal, Payal, Hagymasi, Adam T., Menoret, Antoine, Shen, Chen, Agliano, Federica, Wright, Kyle T., Grady, James J., Ling Kuo, Chia, Ballesteros, Enrique, Claffey, Kevin P., Vella, Anthony T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072002/ https://www.ncbi.nlm.nih.gov/pubmed/31959897 http://dx.doi.org/10.1038/s41388-020-1159-x

Ejemplares similares

Evaluating the glycolytic potential of mouse costimulated effector CD8(+) T cells ex vivo
por: Agliano, Federica, et al.
Publicado: (2022)

A benzimidazole inhibitor attenuates sterile inflammation induced in a model of systemic autoinflammation in female mice
por: Agliano, Federica, et al.
Publicado: (2020)

Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling
por: Agliano, Federica, et al.
Publicado: (2022)

Antigen-specific downregulation of miR-150 in CD4 T cells promotes cell survival
por: Ménoret, Antoine, et al.
Publicado: (2023)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells
por: Sang, Meixiang, et al.
Publicado: (2016)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019)

Epigenetics-related genes in prostate cancer: Expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines
por: ADLER, DAVID, et al.
Publicado: (2012)

CD134/CD137 Dual Costimulation-Elicited IFN-γ Maximizes Effector T Cell Function but Limits Treg Expansion
por: Rose, Marie-Clare St., et al.
Publicado: (2013)

Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer
por: Silvestri, Ida, et al.
Publicado: (2015)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
por: Hwang, Justin H., et al.
Publicado: (2019)

Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization.
por: Sorriento, Daniela, et al.
Publicado: (2014)

Suitability of GRK Antibodies for Individual Detection and Quantification of GRK Isoforms in Western Blots
por: Reichel, Mona, et al.
Publicado: (2022)

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
por: Niemira, Magdalena, et al.
Publicado: (2020)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Cytochrome b5 and Cytokeratin 17 Are Biomarkers in Bronchoalveolar Fluid Signifying Onset of Acute Lung Injury
por: Ménoret, Antoine, et al.
Publicado: (2012)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
por: Tanner, Matthew J., et al.
Publicado: (2011)

Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
por: LIU, TIANCHENG, et al.
Publicado: (2012)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Regulation of Prostate Androgens by Megalin and 25-hydroxyvitamin D Status: Mechanism for High Prostate Androgens in African American Men
por: Garcia, Jason, et al.
Publicado: (2023)

Optimal CD8(+) T cell effector function requires costimulation-induced RNA-binding proteins that reprogram the transcript isoform landscape
por: Karginov, Timofey A., et al.
Publicado: (2022)

Targeting GRK5 for Treating Chronic Degenerative Diseases
por: Marzano, Federica, et al.
Publicado: (2021)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
por: Vickman, Renee E., et al.
Publicado: (2020)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases
por: Hsiao, Jordy J., et al.
Publicado: (2021)

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer
por: Shahinian, Vahakn B, et al.
Publicado: (2015)

Bile acids induce apoptosis selectively in androgen-dependent and -independent prostate cancer cells
por: Goldberg, Alexander A., et al.
Publicado: (2013)

Prostate cancer, insulin, and androgen deprivation therapy
por: Stattin, P, et al.
Publicado: (2003)

Arsenic and Prostate Cancer: Acquiring Androgen Independence
por: Tibbetts, John
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_124bthtiel7lenifjm7p669mh1